APPLICATION
ANDA076350
TYPE
ANDA
ORIGINAL APPROVAL
2002-09-10
LATEST ACTION
2004-02-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter
Products
THYROSAFEOver-the-counter
POTASSIUM IODIDE 130MG · TABLET · ORAL
THYROSAFEOver-the-counter
POTASSIUM IODIDE 65MG · TABLET · ORAL
Approval history
2004-02-13Labeling · Supplement 4AP
2003-05-21Labeling · Supplement 2AP
2003-04-30Labeling · Supplement 1AP
2002-09-10OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.